1-11 of 11
Jin Seok Kim, M.D.
Close
Sort by
Journal Articles

The Role Of Modified Glasgow Prognostic Score As Predictor In Diffuse Large B Cell Lymphoma Treated With The R-CHOP Regimen

Yundeok Kim, Yu Ri Kim, Soo Jeong Kim, MD, Jang Jieun, Hyun Shin-Young, Hwang Dohyu, Jin Seok Kim, M.D., Ph.D., Min Yoo Hong, MD, PhD, June-Won Cheong, Lee Jung Hyun
Journal: Blood
Blood (2013) 122 (21): 4307.
https://doi.org/10.1182/blood.V122.21.4307.4307
Published: 2013
Journal Articles

Phase II Trial of 90 y-Ibritumomab Tiuxetan Treatment as Consolidation After 6th R-CHOP Chemotherapy in Patients with Limited-Stage, Bulky Diffuse Large B Cell Lymphoma.

Deok-Hwan Yang, Won Seog Kim, Cheolwon Suh, MD, Jae-Yong Kwak, Joo-Sep Jung, Sung Hyun Kim, Jin Seok Kim, M.D., Ph.D., Je-Jung Lee, MD, PhD, Hyeoung-Joon Kim
Journal: Blood
Blood (2009) 114 (22): 3751.
https://doi.org/10.1182/blood.V114.22.3751.3751
Published: 2009
Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Kihyun Kim, Seok Jin Kim, MD, PhD, Byung Soo Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Hye Jin Kang, MD, Jin Seok Kim, M.D., Ph.D., Yeung-Chul Mun, Chul Soo Kim, MD, Sang Kyun Sohn, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, Hyeok Shim, Hwi-Joong Yoon, Jong-Youl Jin, Chang-Ki Min, MD, Ho Jin Shin, Hyun Chun Shin, Jong-Ho Won, Je-Jung Lee, MD, PhD, Jung Hye Kwon, Young-Don Joo, MD, PhD, Young Rok Do, M.D., Sung Hyun Kim, Sukjoong Oh, MD, Cheolwon Suh, MD, Junglim Lee, Sung-Soo Yoon, Min Kyoung Kim, Soo-Mee Bang, Hun-Mo Ryoo, Bong-Seog Kim, Hawk Kim, MD, Hyo-Jung Kim, Yang Soo Kim, Chong Won Park, Gyeong-Won Lee, Seongkyu Park, Joon Seong Park, MD, Ho Young Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2009) 114 (22): 4881.
https://doi.org/10.1182/blood.V114.22.4881.4881
Published: 2009
Journal Articles

Infectious Complications in Asian Patients Treated with Alemtuzumab: Results From a Multicenter Study.

Seok Jin Kim, MD, PhD, Ary Harryanto Reksodiputro, Ann-Lii Cheng, Tanin Intragumtornchai, MD, Surapol Issaragrisil, MD, Joon Ho Moon, M.D., Jin Seok Kim, M.D., Ph.D., Je-Jung Lee, Jong Ho Won, Won Seog Kim, Yok Lam Kwong, MD
Journal: Blood
Blood (2009) 114 (22): 5009.
https://doi.org/10.1182/blood.V114.22.5009.5009
Published: 2009
Journal Articles

Relapsed Marginal Zone B-Cell Lymphoma: Clinical Features and Treatment Outcome.

Sung Yong Oh, Won Seog Kim, Seok Jin Kim, MD, PhD, Jin Seok Kim, M.D., Ph.D., Sung Hyun Kim, Dae Ho Lee, M.D., Jong Ho Won, In Gyu Hwang, Min Kyoung Kim, Soon Il Lee, Jong Gwang Kim, M.D., Deok-Hwan Yang, Hye Jin Kang, MD, Chul Won Choi, MD, PhD, Jinny Park, Young Jin Choi, Hyo Jung Kim, MD, PhD, Jung Hye Kwon, Cheolwon Suh, MD, Hyo-Jin Kim
Journal: Blood
Blood (2009) 114 (22): 5017.
https://doi.org/10.1182/blood.V114.22.5017.5017
Published: 2009
Journal Articles

Level of Myeloperoxidase Expression as a Crucial Determinant of Sensitivity of Myeloid Leukemia Cells to Parthenolide-Induced Apoptosis

Soo Jeong Kim, M.D., Ju In Eom, Hye Won Lee, M.D., Hoi Kyung Jeung, Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 2945.
https://doi.org/10.1182/blood.V112.11.2945.2945
Published: 2008
Journal Articles

Bortezomib-Based Induction Therapy Induces Better Responses and Outcomes of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: The Results of Korean Multiple Myeloma Working Party Retrospective Study, KMM84

Seok Jin Kim, MD, PhD, Kihyun Kim, M.D./Ph.D., Jae Hoon Lee, Min Kyoung Kim, Jae-Yong Kwak, Hun-Mo Ryoo, Cheolwon Suh, Sung-Soo Yoon, Moon-Hee Lee, Yeung-Chul Mun, Hyo-Jin Lee, Chang-Ki Min, Jin Seok Kim, M.D., Ph.D., Hwi-Joong Yoon
Journal: Blood
Blood (2008) 112 (11): 5184.
https://doi.org/10.1182/blood.V112.11.5184.5184
Published: 2008
Journal Articles

Central Nervous System Relapses in Patients with Diffuse Large B Cell Lymphoma: Multicenter Retrospective Analysis in Korea

Seok Jin Kim, MD, PhD, Gyeong- Won Lee, Byung Soo Kim, Sung Yong Oh, Ho-Jin Shin, Hee Sook Park, M.D., PhD., Jin Seok Kim, M.D., Ph.D., Hawk Kim, Deok-Hwan Yang, Jinny Park, Won Seog Kim, Cheolwon Suh
Journal: Blood
Blood (2008) 112 (11): 5314.
https://doi.org/10.1182/blood.V112.11.5314.5314
Published: 2008
Journal Articles

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

Soo Jeong Kim, M.D., Haeng Im Jung, Hye Won Lee, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 2644.
https://doi.org/10.1182/blood.V112.11.2644.2644
Published: 2008
Journal Articles

mTOR Inhibitor Rapamycin Interacts Synergistically with Farnesyltransferase Inhibitor FTI-277 To Induce Growth Inhibition in Human Leukemia Cells.

June-Won Cheong, MD, PhD, Ju In Eom Eom, Hye Won Lee, M.D., In-Hae Park, M.D., Yuri Kim, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1821.
https://doi.org/10.1182/blood.V110.11.1821.1821
Published: 2007
Journal Articles

Akt/PKB Activation-Induced Cytoplasmic Mislocalization of p27Kip1 Protein Is Mediated by Jab1 Shuttling in Human Myeloid Leukemia Cells.

Yoo-Hong Min, M.D., Ph.D., Ju In Eom, Ae Jin Choi, Jee Young Lee, Jin Seok Kim, M.D., Seung Tae Lee, M.D., June-Won Cheong, M.D.
Journal: Blood
Blood (2004) 104 (11): 4461.
https://doi.org/10.1182/blood.V104.11.4461.4461
Published: 2004